131 related articles for article (PubMed ID: 38103940)
21. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
Lee AI; Wong CA; Healy L; Toledo P
Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
[TBL] [Abstract][Full Text] [Related]
22. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
[TBL] [Abstract][Full Text] [Related]
23. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Trials; 2016 Mar; 17():155. PubMed ID: 27004531
[TBL] [Abstract][Full Text] [Related]
25. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation.
Wing DA; Paul RH
Am J Obstet Gynecol; 1998 Jul; 179(1):94-9. PubMed ID: 9704771
[TBL] [Abstract][Full Text] [Related]
26. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.
El Behery MM; El Sayed GA; El Hameed AA; Soliman BS; Abdelsalam WA; Bahaa A
J Matern Fetal Neonatal Med; 2016; 29(8):1257-60. PubMed ID: 25946576
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
[TBL] [Abstract][Full Text] [Related]
28. The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery.
Wang LY; Wang J; Dong JH; Ping ZP; Chen XZ; Wei CN
Front Pharmacol; 2023; 14():1211693. PubMed ID: 37576820
[No Abstract] [Full Text] [Related]
29. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial.
Balki M; Downey K; Walker A; Seaward G; Carvalho JCA
Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897
[TBL] [Abstract][Full Text] [Related]
30. European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[Formula: see text].
; Nunes I; Dupont C; Timonen S; ; Ayres de Campos D; Cole V; Schwarz C; Kwee A; Yli B; Vayssiere C; Roth GE; Gliozheni E; Savochkina Y; Ivanisevic M; Janku P; Timonen S; Daskalakis G; Beke A; Santo S; Druškovič M; Duvekot JJ; Farr A; Dreyfus M
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7166-7172. PubMed ID: 34470113
[TBL] [Abstract][Full Text] [Related]
31. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
32. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
33. Survey on the use of oxytocin for cesarean section.
Marcus HE; Fabian A; Lier H; Dagtekin O; Böttiger BW; Teschendorf P; Petzke F; Valter M; Spöhr F
Minerva Anestesiol; 2010 Nov; 76(11):890-5. PubMed ID: 20592672
[TBL] [Abstract][Full Text] [Related]
34. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis.
Saccone G; Ciardulli A; Baxter JK; Quiñones JN; Diven LC; Pinar B; Maruotti GM; Martinelli P; Berghella V
Obstet Gynecol; 2017 Nov; 130(5):1090-1096. PubMed ID: 29016497
[TBL] [Abstract][Full Text] [Related]
35. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
[TBL] [Abstract][Full Text] [Related]
36. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
[TBL] [Abstract][Full Text] [Related]
37. Is high-dose misoprostol able to lower the incidence of cesarean section? A randomized controlled trial.
de la Torre S; Gilson GJ; Flores S; Curet LB; Qualls CE; Rayburn WF
J Matern Fetal Med; 2001 Apr; 10(2):85-90. PubMed ID: 11392598
[TBL] [Abstract][Full Text] [Related]
38. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
Kovacheva VP; Soens MA; Tsen LC
Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
Dyer RA; Butwick AJ; Carvalho B
Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for complete uterine rupture.
Al-Zirqi I; Daltveit AK; Forsén L; Stray-Pedersen B; Vangen S
Am J Obstet Gynecol; 2017 Feb; 216(2):165.e1-165.e8. PubMed ID: 27780708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
